BAM
OYST

Belpointe Asset Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Belpointe Asset Management’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10
Closed -$112 – 3928
2022
Q4 		$112 Buy
+10
New +$97 ﹤0.01% 3668

Other funds holding OYST

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Belpointe Asset Management's OYST Position: Q1 2023 in Review

Belpointe Asset Management sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 10 shares — an estimated $112 sold.

Belpointe Asset Management first reported a position in OYST in Q4 2022 and held it in 1 quarter. The position peaked at $112 in Q4 2022. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

  • Belpointe Asset Management reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 10 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $112.
  • Belpointe Asset Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Belpointe Asset Management's Oyster Point Pharma, Inc. Common Stock position peaked at $112 in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Belpointe Asset Management's 13F filing for Q1 2023, filed 15 May 2023.